Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 992Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2APOTEX INC

02 2TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BROMAZEPAM

Brand Name : APO-BROMAZEPAM

Dosage Form : TABLET

Dosage Strength : 6MG

Packaging : 1,00,500

Approval Date :

Application Number : 2177188

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BROMAZEPAM

Brand Name : APO-BROMAZEPAM

Dosage Form : TABLET

Dosage Strength : 3MG

Packaging : 1,00,500

Approval Date :

Application Number : 2177161

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BROMAZEPAM

Brand Name : TEVA-BROMAZEPAM

Dosage Form : TABLET

Dosage Strength : 3MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2230584

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

BROMAZEPAM

Brand Name : TEVA-BROMAZEPAM

Dosage Form : TABLET

Dosage Strength : 6MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2230585

Regulatory Info : Targeted (CDSA IV)

Registration Country : Canada

blank